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ABSTRACT Regulation of the structural equilibrium of G-quadruplex-forming sequences located in the promoter regions of
oncogenes by the binding of small molecules has shown potential as a new avenue for cancer chemotherapy. In this study,
microcalorimetry (isothermal titration calorimetry and differential scanning calorimetry), electronic spectroscopy (ultraviolet-
visible and circular dichroism), and molecular modeling were used to probe the complex interactions between a cationic
porphryin mesotetra (N-methyl-4-pyridyl) porphine (TMPyP4) and the c-MYC PU 27-mer quadruplex. The stoichiometry at
saturation is 4:1 mol of TMPyP4/c-MYC PU 27-mer G-quadruplex as determined by isothermal titration calorimetry, circular
dichroism, and ultraviolet-visible spectroscopy. The four independent TMPyP4 binding sites fall into one of two modes. The two
binding modes are different with respect to afﬁnity, enthalpy change, and entropy change for formation of the 1:1 and 2:1, or 3:1
and 4:1 complexes. Binding of TMPyP4, at or near physiologic ionic strength ([K1] ¼ 0.13 M), is described by a ‘‘two-
independent-sites model.’’ The two highest-afﬁnity sites exhibit a K1 of 1.6 3 10
7 M-1 and the two lowest-afﬁnity sites exhibit a
K2 of 4.2 3 10
5 M-1. Dissection of the free-energy change into the enthalpy- and entropy-change contributions for the two
modes is consistent with both ‘‘intercalative’’ and ‘‘exterior’’ binding mechanisms. An additional complexity is that there may be
as many as six possible conformational quadruplex isomers based on the sequence. Differential scanning calorimetry
experiments demonstrated two distinct melting events (Tm1 ¼ 74.7C and Tm2 ¼ 91.2C) resulting from a mixture of at least two
conformers for the c-MYC PU 27-mer in solution.
INTRODUCTION
In anticancer drug discovery, shifting the focus to structural
selectivity instead of sequence selectivity is a promising
means to improve drug speciﬁcity and afﬁnity for speciﬁc
biotargets. Recently the binding of small molecules to
higher-order DNA structures, such as G-quadruplex DNA,
has been the focus of a new avenue for the treatment
of cancer (1–5). It has been proposed that the formation of
G-quadruplexes can occur in the promoter regions of 17 of
the 30 known oncogenes (e.g., c-MYC, VEG-F, BCL-2, etc.)
as well as the human telomere (5–7). The c-MYC protein has
been identiﬁed as one of the main activation factors for the
hTERT catalytic domain of the telomerase enzyme (8–15).
The activation of the telomerase enzyme has been identiﬁed
in .60% of cancer cells of different types (16,17). Some
studies have shown that under physiological conditions the
formation of the G-quadruplex is not highly favored (18–20).
However, binding a drug with high afﬁnity for G-quadruplex
DNA can drive this equilibrium toward the formation of
G-quadruplex structures (21–25). Potential applications of
binding drugs to G-quadruplex DNA include downregula-
tion of genes important to the development and/or endurance
of multiple types of cancer (10,11,26–33).
The afﬁnity of the model drug mesotetra (N-methyl-4-
pyridyl) porphine (TMPyP4) for G-quadruplex DNA has
been previously established (1,30,34–38). The mechanism
by which this compound binds to G-quadruplex DNA has
been a topic of dispute. Haq et al. described the binding of
TMPyP4 to a series of model quadruplex structures by an
exclusively intercalative mechanism in which the number of
bound TMPyP4 molecules/quadruplex was consistent with
the number of ‘‘intercalation slots’’ (39). Seenisamy et al.
have suggested that there are only two possible binding sites
on the G-quadruplex, both of which are on the exterior ends
of the quadruplex structure (40). Interestingly, Seenisamy
et al. noted a change in titration circular dichroism (CD)
spectra for the c- MYC 27-mer quadruplex up to four mole
ratios of TMPyP4. In light of these discrepancies, the main
purpose of this study was to develop a better understanding
of the location and number of binding sites involved in the
binding of TMPyP4 (or other planar heterocyclic com-
pounds) to G-quadruplex DNA. Our data support both
intercalation and end-capping mechanisms for binding
saturating amounts of TMPyP4 to the c-MYC quadruplex.
MATERIALS AND METHODS
The c-MYC 27-mer of sequence 59-TGGGGAGGGTGGGGAGGGTGGG-
GAAGG and molecular mass 8687.4 g/mol was obtained from Oligos Etc.
(Wilsonville, OR). c-MYC 27-mer stock solutions were prepared by
dissolution of weighed amounts of the oligonucleotide in KBPES buffer (.01
M KH2PO4, .01 M K2HPO4, .001 M EDTA, 0.02–0.6 M KCl, KOH added
dropwise to pH 7.0). A small volume (2 mL) of the oligonucleotide stock
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solution was exhaustively dialyzed (1000 molecular-weight cutoff mem-
brane) against two changes of buffer (1 L, 24 h each) at 4C. The con-
centrations of all the DNA solutions were veriﬁed using ultraviolet-visible
(UV-Vis) spectrophotometry with molar extinction coefﬁcients determined
using a nearest-neighbor calculation for single-stranded DNA (41) and the
absorbance of thermally denatured constructs extrapolated back to 25C,
and/or a total-phosphate-analysis technique (42). The extinction coefﬁcient
determined for the 27-mer quadruplex by these techniques was e260¼ 2.1533
105 M1 cm1.
TMPyP4 was obtained from Frontier Scientiﬁc (Logan, Utah). All ligand
solutions were prepared by dissolution of a weighed amount of TMPyP4 and
using a measured volume of the ﬁnal dialysate from the appropriate oli-
gonucleotide solution preparation as the buffer. Concentrations for TMPyP4
solutions were veriﬁed with absorbance measurements using a published
molar extinction coefﬁcient of e424 ¼ 2.26 3 105 M1 cm1 (39).
Isothermal titration calorimetry (ITC) experiments were performed using
a Microcal VP-ITC (Microcal, Northampton, MA). All of the oligonucle-
otide titrations were done by overﬁlling the ITC cell with ;1.5 mL of
nominally 25 mM oligonucleotide solution and adding;60 (5 mL) to 140 (2
mL) injections of nominally 8 3 104 M TMPyP4. Titrations were done at
ﬁve temperatures from 5 to 45C and at ﬁve supporting electrolyte con-
centrations of 0.02–0.6 M KCl. Typically, three replicate titration exper-
iments were performed. Due to the nonsigmoidal shape of the thermogram
and the obvious presence of at least two independent binding processes, the
thermograms (integrated heat/injection data) obtained in ITC experiments
were ﬁt with our own ‘‘independent-sites’’ model and a ﬁtting algorithm
developed for use with Mathematica 5.0 software. The data were ﬁt within
experimental error with a ‘‘two-independent-sites’’ model. Simpler models
were unable to ﬁt the data within experimental error and more complex
models were not justiﬁed. (The model equations and a representative ﬁt are
described in the Results section and shown in Fig. 1 A.) Values forDG1 (K1),
DG2 (K2), DH1, DH2, –TDS1, –TDS2, n1, and n2 were extracted directly from
the ﬁts obtained for our two-independent-sites model. Error analysis was
accomplished using a Monte Carlo procedure. DCp1 and DCp2 values were
obtained by plotting DHi versus temperature (C) and ﬁtting the temperature
data with a simple linear-regression model.
The differential scanning calorimetry (DSC) experiments were performed
using a Microcal VP-DSC instrument. The c-MYC 27-mer concentration
was nominally 1 3 104 M and TMPyP4 concentrations ranged from 5 3
105 M to slightly greater than 1 3 104 M. Experiments covered the
temperature range from 10 to 110C and the scan rate was set to 90C/h. A
typical experiment involved collecting three heating scans for each ﬁlling,
and replicate measurements were done on separate ﬁllings of the DSC cell.
The DSC data were analyzed using the Origin 7.1 software and were ﬁt
for two ‘‘two-state’’ processes. The Origin analysis reported values for the
melting temperature, Tm, and the calorimetric, DHcal, and van’t Hoff
enthalpies, DHVH, for each observed transition.
UV-vis spectroscopy titrations were done using an Agilent 8453 diode
array (Agilent, Santa Clara, CA). DNA and ligand solutions for UV-vis
titrations were prepared at identical concentrations of 32 mM (BPES buffer).
A titration experiment was done in two parts. In the ﬁrst part, 1 mL of the
dilute c-MYC 27-mer solution (32 mM) was placed into a standard quartz
cuvette and 25 3 50-ml injections of the TMPyP4 solution were added
manually. In the second part, 1 mL of the diluteTMPyP4 solution (32 mM)
was placed into a standard quartz cuvette and 25 3 50-ml injections of the
c-MYC 27-mer solution were added. Spectra from 200 to 600 nm were re-
corded after each injection in both parts of the titration experiment. In this
manner, the entire mole fraction range of 0–1 was covered and there were ﬁve
overlapping points at the end of each ‘‘half-titration.’’ The difference spectra
used to construct the Job plot were obtained by subtraction of the spectra for
TMPyP4 solutions from the spectra for the same concentration of TMPyP4 in
the presence of the c-MYC 27-mer. The Job plot was analyzed to determine
the mole fractions corresponding to speciﬁc TMPyP4/DNA complexes.
CD experiments were performed using a JASCO 810 CD spectropolar-
imeter spectroscopy instrument (Jasco, Tokyo, Japan) with spectra collected
over the wavelength range 200–450 nm. The c-MYC 27-mer concentration
was nominally 2 3 106 M and ligand concentration ranged from 0 to
slightly greater than 83 106 M. Concentrations of the oligonucleotide and
TMPyP4 were veriﬁed using UV-vis absorbance measurements. CD titration
data were collected after manual addition of aliquots of the dilute TMPyP4
titrant using a calibrated micropipette. CD spectra were collected at mole
ratios of 0:1, 1:1, 2:1, 3:1, and 4:1 for the TMPyP4/c-MYC 27-mer.
RESULTS
Fig. 1 A shows typical integrated heat data for the titration
of the c-MYC PU 27-mer with TMPyP4 along with a two-
independent-sites ﬁt. (The raw ITC data corresponding to the
same experiment are given in Supplementary Material as
Fig. S1.) The ITC data demonstrate a stoichiometry of 4:1 for
the TMPyP4:c-MYC 27-mer complex. The microcalorim-
etric signal and integrated heat data are complex and are
consistent with at least two independent binding processes
occurring during complex formation before drug saturation.
FIGURE 1 (A) Representative nonlinear regression ﬁt of the ITC
integrated heat data for TMPyP4 binding to the 27-mer quadruplex DNA
construct in 100 mM KCl at 25C. The ﬁt is shown as a solid line and is the
result from the ‘‘multiple-independent-sites’’ model. The ﬁt line shown
above was obtained with a user-deﬁned ﬁtting routine coded in Mathematica
5.0 by our laboratory. (B) Dissection of the Gibb’s free energy change for
binding TMPyP4 to both mode 1 and mode 2 sets of equivalent binding sites
of the 27-mer quadruplex in 100 mM KCl phosphate buffer (100 mM KCl,
30 mM phosphate buffer, pH 7.0). The ﬁrst bar (vertically hatched)
represents the free-energy change, the second bar (dotted) the enthalpy
change, and the third bar (horizontally hatched) the –TDS for modes 1 and 2,
as noted in the ﬁgure. All parameter values are favorable (negative) with the
exception of the mode 2 entropic term.
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These data are not typical for either a one-site or two-site ITC
titration since the stronger binding interaction has the smaller
exothermic heat of binding generating the complete curve
shape shown in Fig. 1 A. Fig. 1 B shows the dissection of the
free-energy changes for binding modes 1 and 2 into the
enthalpy and entropy contributions.
The ITC thermograms were modeled using a multiple
independent binding site nonlinear regression algorithm. The
algorithm was implemented into the Mathematica 5.0 pro-
gramming language and is deﬁned by Eqs. 1 and 2.
Qj ¼ ½XKj
11 ½XKj (1)




Equations 1 and 2 describe the equilibrium and mass-
balance relationships for the system being studied, where Qj
is the fraction of site j occupied by ligand, Xt is the total
ligand concentration, [X] is the free ligand concentration, Mt
is the total macromolecule concentration, Kj is the binding
constant of process j, and nj is the total stoichiometric ratio
for process j. Each of the equations is deﬁned for k-binding
sites, and solutions for any k-site binding process can be
deﬁned. Substituting Eq. 1 into Eq. 2 and expanding the
polynomial in terms of the indeterminant [X] results in a (k1
1) degree polynomial. Thus, to determine a solution for a
k-site independent binding process, roots of a (k1 1) degree
polynomial must be found. A Mathematica 5.0 ﬁtting
algorithm was used to obtain a real root of the (k 1 1)
degree polynomial. Substitution of [X] into Eq. 1 allows the
fraction of binding site j that is occupied to be calculated.






DQðiÞ ¼ QðiÞ  Qði 1Þ (4)
The total heat produced can be calculated from Eq. 3,
where Vo is the initial volume of the sample cell and DHj is
the molar enthalpy change for process j. The differential heat
is deﬁned by Eq. 4, where i represents the injection number.
Nonlinear regression was performed on parameters Kj, nj,
and DHj to obtain a best ﬁt to the experimental data.
In the case of the quadruplex/TMPyP4 system, where
saturation occurs at 4 mol drug/mol oligonucleotide, there
are four unique binding sites and 64 microstate species
possible as the titration proceeds from zero drug bound to
saturation. Deﬁnitions of the macrobinding constants deter-
mined from these nonlinear regression ﬁt models are given in
Eqs. 5–8.
Q1D K1 QD K1 ¼ ½QD½Q½D ð5Þ
QD1D K2 QD2 K2 ¼ ½QD2½QD½D ð6Þ
QD21D 
K3
Q3D3 K3 ¼ ½QD3½QD2½D ð7Þ
QD31D 
K4
Q3D4 K4 ¼ ½QD4½QD3½D: ð8Þ
Since the quadruplex/TMPyP4 interaction can be modeled
within experimental error only with two independent modes
each having a stoichiometry of 2:1, the binding afﬁnities
for the ﬁrst and second drug-binding interactions must be
approximately equal, and the binding afﬁnities for the third
and fourth interactions must be approximately equal as well.
Throughout the rest of this article, the parameter K1 refers to
both of the highest-afﬁnity sites (K1 and K2) in Eqs. 5 and 6
above, whereas the parameter K2 refers to both of the lower-
afﬁnity sites (K and K4) in Eqs. 7 and 8 above. The nonlinear
regression ﬁt (Fig. 1 A, solid line) is from a two-independent-
sites model and the best-ﬁt parameters listed in Tables 1 and
2. TMPyP4 binding to the two highest-afﬁnity quadruplex
sites, K1  0.55 3 107 M1, is ; 20 times tighter than
binding to the two lower-afﬁnity sites, K2  0.024 3 107
M1. @DG1–2 is approximately2 kcal/mole, and @DH1–2 is
approximately 16 kcal/mole. The large unfavorable change
in the enthalpy change between mode 1 binding and mode 2
binding is obviously compensated to a large degree by a
more favorable entropy change for the latter process. The
free-energy change for each binding mode was parsed into
the respective enthalpy and entropy contributions (Fig. 1 B).
The two binding modes have distinctly different energetic
proﬁles. The ﬁrst is driven mainly by a favorable entropic con-
tribution, whereas the second is driven by a large favorable
enthalpy change. These energetic proﬁles are similar to those
exhibited by duplex DNA interacting with groove binders
and intercalators, respectively (43–47).
TMPyP4 titrations of the c-MYC 27-mer were done at
ﬁve concentrations (50 # [K1] $ 630 mM) of the support-
ing electrolyte. The ITC results obtained for the highest
potassium concentration (630 mM) are neither tabulated nor
discussed, as the binding of TMPyP4 was too weak at this
salt concentration (K2, 13 10
3 M1), leaving the binding
data subject to larger errors. The thermodynamic parameters
TABLE 1 ITC-derived thermodynamic parameters for the
27-mer quadruplex construct binding TMPyP4 in variable salt













20 43 (63) 10.4 18 (60.6) 8.5
50 25 (62) 10.1 7.0 (60.2) 8.0
100 5.4 (6.5) 9.2 2.0 (60.1) 7.3
200 11 (61) 9.6 2.3 (60.1) 7.3
Parameters are for the two-independent-sites binding model. The uncer-
tainties listed for DHi were determined by Monte Carlo analysis.
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obtained from ﬁtting these ITC titrations are given in Tables
1 and 2. Over the range of 20–200 mM added KCl, the free-
energy, enthalpy, and entropy changes seem to be relatively
insensitive to the ionic strength for either binding mode.
Increasing the ionic strength decreases the afﬁnity for both
binding processes. For all salt solutions ([K1]# 230mM), the
dissection of the free energy of binding for both bindingmodes
exhibited the same energetic proﬁles discussed above. These
results are somewhat surprising in light of known polyelec-
trolyte effects and the fact that ionic strength and the speciﬁc
cation are known to affect the structure of the quadruplex (48).
The temperature studies allowed us to estimate the DCp
for binding and to evaluate the role of water in the TMPyP4/
quadruplex complex formation. Again the titration data were
best ﬁt with a two-independent-sites model at all tempera-
tures. The best-ﬁt parameters for these experiments are given
in Tables 3 and 4. The heat-capacity changes were calculated
by plotting the DHi values versus temperature and ﬁtting the
data with a simple linear-regression line for each binding
mode. The heat-capacity changes, DCp1 and DCp2, were 31
and 58 cal/molK, respectively. These DCp values are small
and indicate only small net changes in structured solvent on
binding. Again, this result is interesting since solvation is im-
portant to DNA structure and many ligands bind to DNA with
the concomitant expulsion of groove or spine water (49–51).
The thermal stability of the c-MYC 27-mer was measured
using DSC. The melting curve (Fig. 2 A) is well ﬁt by
summation of two two-state thermal transitions. The lower
melting transition has a Tm of 76.4C and the higher melting
transition has a Tm of 91.2C at 130 mM potassium. The
two separate transitions indicate the presence of 1), two
independent melting domains in a single structure; 2), a
stepwise melting process for a single structure, in which a
conformation change is followed by complete denaturation
(sequential A/B/C); or 3), two different quadruplex
conformers existing simultaneously in solution, each with its
own unique melting temperature. Although the DSC data
cannot unambiguously be used to identify which of these
three possible processes is occurring, we believe the third
process seems to be the most reasonable. This is based on the
fact that the enthalpy changes for the two processes are
similar in magnitude and from the fact that the equilibrium
between these two conformations can be shifted by either
drug binding or by the association of a shorter oligonucle-
otide having complimentary duplex-forming sequences and
noninteractive bases directly adjacent to the quadruplex (data
not shown). The relative percentages of each conformer at
25C are;30 and 70% for the low-melting and high-melting
conformers, respectively (in the absence of either TMPyP4
or the ‘‘capping sequence’’ just mentioned). The DSC results
obtained for the highest potassium concentration (630 mM)
are neither tabulated nor discussed, as the melting temper-
ature of the quadruplex at this salt concentration was at or
above the upper temperature limit of the instrument, leaving
the melting data subject to larger errors. A plot of the DSC
data for denaturation of the 27-mer G-quadruplex in 50–230
mM [K1] is given in Fig. 2 B. (The enthalpy change data
obtained from the two-state ﬁts for both thermal transitions
in Fig. 2 B have been plotted as a function of melting
temperature in Fig. S2 in Supplementary Materials). In the
20-mM salt solution, the lower melting transition has a Tm of
67.5C and the higher melting transition has a Tm of 81.3C.
In the 200-mM salt solution, the lower melting transition has
a Tm of 83.4C and the higher melting transition has a Tm of
97.4C. As expected, the thermal stability of the quadruplex
increased continuously with increasing ionic strength. As we
mentioned above, we have analyzed our DSC data based on
a model that assumes that each two-state transition observed
in the thermogram reﬂects a uniquely folded conformation of
the oligonucleotide. All of the thermograms are composed of
at least two independent two-state thermal transitions.
UV-vis titration spectra for the complexation of TMPyP4
by G-quadruplex oligonucleotide show an obvious red shift
TABLE 2 ITC-derived thermodynamic parameters for the
27-mer quadruplex construct binding TMPyP4 in variable salt











20 1.4 (60.07) 9.0 13.1 (60.1) 4.6
50 1.7 (60.07) 8.4 9.0 (60.1) 1.0
100 2.6 (60.06) 6.6 9.1 (60.1) 1.8
200 1.8 (60.07) 7.8 11.9 (60.1) 4.6
Parameters are for the two-independent-sites binding model. The uncer-
tainties listed for DHi were determined by Monte Carlo analysis.
TABLE 3 ITC-derived thermodynamic parameters for the
27-mer quadruplex construct binding TMPyP4 in 100 mM KCl












5 26 (69) 9.4 2.2 (60.1) 6.8
15 12 (63) 9.3 2.7 (60.1) 7.2
25 5.4 (60.5) 9.2 2.0 (60.1) 7.3
37 1.7 (60.4) 8.8 1.1 (60.1) 7.2
45 3.7 (60.8) 9.5 1.3 (60.1) 7.4
Parameters are for the two-independent-sites binding model. The uncer-
tainties listed for DHi were determined by Monte Carlo analysis.
TABLE 4 ITC-derived thermodynamic parameters for the
27-mer quadruplex construct binding TMPyP4 in 100 mM KCl










5 4.7 (60.7) 4.7 9.3 (60.3) 2.5
15 2.6 (60.1) 6.7 9.3 (60.2) 2.1
25 2.6 (60.1) 6.6 9.1 (60.1) 1.8
37 2.7 (60.1) 6.1 9.2 (60.1) 2.0
45 3.5 (60.2) 6.0 8.3 (60.1) 0.9
Parameters are for the two-independent-sites binding model. The uncer-
tainties listed for DHi were determined by Monte Carlo analysis.
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in the absorbance maximum, lmax. The lmax shifts from
422 to 440 nm (18 nm) and the absorbance is attenuated by
;35% (hypochromicity). The shift in wavelength and the
hyperchromicity are indicative of intercalation of the
TMPyP4 molecule into the quadruplex structure (52–54).
We note that the absence of a sharp isobestic point is the
probable result of multiple conformatioins for the quad-
ruplex and quadruplex-drug complexes. Examination of the
Job plot (Fig. 3 A) shows several slope changes between
approximately linear regions. The last four endpoints cor-
respond to stoichiometric ratios of 1:1, 2:1, 3:1, and 4:1 mol
TMPyP4/mol c-MYC 27-mer. The stoichiometric ratio at
saturation (4:1) is consistent with the overall stoichiometry
determined by ﬁtting the ITC data in this article and with CD
data analyzed in Hurley et al. (40).
As shown in Fig. 4 A, CD measurements of the 27-mer
quadruplex construct demonstrated a spectral signature
consistent with G-quadruplex DNA that agreed very well
with previously published spectra for the same sequence
(40). The CD spectra for the naked quadruplex along with
solutions containing 1:1, 2:1, 3:1, and 4:1 mol TMPyP4/
c-MYC 27-mer are shown in Fig. 4 A. Titration of the qua-
druplex with TMPyP4 in the CD instrument demonstrated
that the quadruplex structure was still present after saturation
with TMPyP4. Fig. 4 B shows that bound TMPyP4 does
not have an induced CD signal under these experimental
conditions, which are different (e.g., with respect to buffer,
supporting electrolytes, temperature, drug and oligonucleo-
tide concentrations, etc.) from those explored in Seenisamy
et al. (40). The absorbance of the added TMPyP4 at 440 nm
was attenuated by;50% for the last two mole ratios of added
drug. The TMPyP4 absorbance (at 440 nm) increased ac-
cording to the free drug extinction coefﬁcient once the qua-
druplex had been saturated with TMPyP4 (4mol TMPyP4/mol
FIGURE 3 (A) Job plot of difference spectra collected at 450 nm plotted
against mole fraction of added TMPyP4. The linear regression intersections
correspond to mole fractions of 0.5, 0.66, 0.75, and 0.8. These intersections
represent binding stoichiometries of 1:1, 2:1, 3:1, and 4:1, respectively. (B)
Plot of absorbance versus wavelength for incremental additions of TMPyP4
into 27-mer G-quadruplex oligonucleotide. Total solution concentration was
kept constant at 32 mM throughout the addition of ligand. The plot shows
a characteristic red shift from 422 nm to 440 nm consistent with an inter-
calative drug binding mechanism.
FIGURE 2 (A) Thermal denaturation of the 27-mer quadruplex construct in
100 mM KCl, 20 mM phosphate buffer, pH 7.0. The raw DSC excess heat
capacity signal has been deconvoluted into two ‘‘two-state’’ processes using
Origin 7.0. The Tm values for the lower-melting conformer and the higher-
melting conformers are 76.4 and 91.2C, respectively. (B) Thermal denatur-
ation of the 27-mer quadruplex construct in 20, 50, 100, 200, and 600mMKCl
(all of these with 30 mM phosphate buffer, pH 7.0). The curves from left to
right are in the following order: 20, 50, 100, 200, and 600 mM KCl.
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27-mer quadruplex). The UV-vis absorbtion spectrum 200–
440 nm for the solution containing TMPyP4 and the 27-mer
qudruplex with a ratio of 4 mol drug/mol quadruplex is
shown in Fig. 4 C.
DISCUSSION
The ITC titrations of the c-MYC 27-mer with TMPyP4
exhibit two independent binding processes with different
energetic proﬁles. The UV-vis and CD titrations indicate the
intercalation of TMPyP4 into the quadruplex structure as
well as the persistence of the quadruplex structure through
saturation with TMPyP4. The stoichiometry of the TMPyP4
binding interaction is consistently 4 mol TMPyP4/mol
c-MYC 27-mer at saturation. It is almost intuitive that there
must be some combination of interior and exterior binding
processes in play to form the 4:1 TMPyP4/G-quadruplex
complex. As shown in Fig. 1 B, the energetic proﬁles for
mode 1 and mode 2 binding sites are very different. Dis-
section of the free energy changes for binding TMPyP4 to
the four independent sites in the quadruplex indicates that
the highest-afﬁnity sites (mode 1, presumably binding to the
two end-cap regions) have an energetic proﬁle consistent
with ‘‘groove-like’’ binding interactions in duplex DNA
(43–47). Dissection of the free-energy change for binding to
the lower-afﬁnity sites (mode 2, presumably binding to the
two intercalation cavities) exhibits a proﬁle similar to that
shown for intercalation into duplex DNA (43–47). The two-
independent-sites model is the simplest model that can ﬁt
the titration data and the derived K, DG, DH, and TDS
values for the two sites are weighted averages of all of the
microstate values (55).
The free energy changes (and energetic proﬁles) for
binding TMPyP4 to the c-MYC 27-mer by either binding
mode are approximately independent of both ionic strength
and temperature. The apparently small electrostatic contri-
bution to the TMPyP4 afﬁnity is consistent with the results of
the computational modeling, indicating that there are no
signiﬁcant electrostatic interactions in the formation of the
end-capped complex, and very few weak (3.5- to 4-A˚)
electrostatic interactions in the formation of the intercalation
complex (Supplementary Material). The limited temperature
dependence, i.e., the small positive values for DCp1 and
DCp2, suggests that there must be little or no net solvent
restructuring accompanying complex formation (52).
The thermal stability of the quadruplex was shown to
increase with either TMPyP4 binding or increased ionic
strength. At 630 mM ionic strength, little if any TMPyP4
FIGURE 4 (A) Circular dichroism spectra of the 27-mer quadruplex
interacting with TMPyP4 in 100 mMKCl, 30 mM phosphate buffer, pH 7.0.
The CD spectra for both the naked and the TMPyP4-saturated quadruplex
show the characteristic maximum at 264 nm typical of parallel G-quadruplex
DNA. (B) Circular dicroism spectrum for the TMPyP4 saturated c-MYC 27-
mer with data collected out to 450 nm showing no induced CD for the drug
at 440 nm. (C) Absorbance spectrum for the TMPyP4-saturated c-MYC
27-mer demonstrating attenuation of the absorbance peak for TMPyP4
consistent with intercalation of TMPyP4 into the c-MYC 27-mer structure.
FIGURE 5 Plot of the melting temperature (Tm) versus the log of the
potassium ion concentration (log[K1]). Both Tm1 (d) and Tm2 (n) exhibit a
linear dependence on the log of the potassium ion concentration. The log
function was chosen to estimate the differential ion binding term by use of
Eq. 9. The linear regression ﬁts shown are described by the following
equations: for the Tm1 data, the equation is Tm1 ¼ 23.8 3 log[K1] 1 26.7,
and for the Tm2 data, the equation is Tm2 ¼ 24.4 3 log[K1] 1 39.6. The
correlation coefﬁcients for these ﬁts are 0.9946 and 0.9991 for the Tm1 and
Tm2 equations, respectively.
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binding was observed. Presumably, this is an indication that
at high potassium concentrations, potassium ions might
occupy TMPyP4 binding sites. We suspect that the effect of
NaCl would be different; the salt dependence of both the
quadruplex stability and TMPyP4 binding is really a com-
bination of an ionic strength effect (screening) and a more
speciﬁc counterion binding effect on the structure of the
quadruplex in solution (e.g., Na1 versus K1).
We have used Eq. 9 to estimate the differential binding
term for potassium ion binding to the quadruplex (56,57).
Dn ¼ a3ðDH=R3 T2mÞ3 ðdTm=dlog½K1 Þ=2:303 (9)
In Eq. 9, Dn is deﬁned as the number of differentially
bound ions that are released during quadruplex unfolding
to a random coil, a is the activity coefﬁcient for the released
ion, DH is the enthalpy change for the quadruplex to ran-
dom coil transition, Tm is the transition temperature, and
dTm/dlog[K
1] is determined from a plot of the melting
temperature of the quadruplex versus the log of the potas-
sium ion concentration. The value of Dn for each of the
two transitions is comparable (Dn1 ¼ 0.53, and Dn2 ¼ 1.01).
See Fig. 5. Either value seems small in light of published
structures showing three speciﬁcally bound potassium ions
in the typical G-quadruplex structure (22). We are not
convinced that the difference between the Dn values
calculated from Eq. 9 and the number of potassium ions
placed in the crystal structure is signiﬁcant. We actually have
shown in the accompanying supplementary materials that
there is a simple linear relationship between the Tm and
[K1]1/2, indicating that the change in Tm can be just as
effectively predicted as a function of the activity coefﬁcient
for the potassium ion.
One conclusion, drawn in part from DSC obtained at low
TMPyP4/quadruplex ratios (data not shown), is that the
lower-melting conformer seen in the DSC experiment (Fig. 2
A) exhibits the highest average afﬁnity for TMPyP4. It is
well known that the c-MYC G-rich promoter sequence is
theoretically capable of forming a variety of conformation
isomers (40,58). Patel has reported on NMR structures for
two mutant sequences exhibiting folding patterns that utilize
different G-runs in the complete 27-mer wild-type sequence
and have 1:2:1 bases in the connecting loops or 1:6:1 bases
in the connecting loops (58). We have done DSC experi-
ments with a mutant that forms only the 1:6:1 loop isomer,
and this sequence exhibits a single two-state melting tran-
sition with a Tm that is equal to the Tm of the lower-melting
conformer in the wild-type c-MYC 27-mer quadruplex
studied here. We might speculate that 1:2:1and 1:6:1 loop
isomers are in equilibrium in the wild-type c-MYC 27-mer
solution and that binding TMPyP4 to the lower-melting
conformer would result in a concomitant transition from the
1:2:1 isomer to the 1:6:1 isomer. Therefore, the differences
in the total heat seen in the titrations done at different salt
concentrations may be due not only to differences in the
enthalpy values for TMPyP4 binding, but also to the in-
clusion of some refolding heat in the total heat of binding
measured in these solutions.
Seenisamy et al. reported that signiﬁcant changes in the
quadruplex circular dichroism spectra were observed to occur
upon the addition of TMPyP4 up to a mole ratio of 4 mol
drug/mol oligonucleotide (40). It must be noted that these CD
data were collected in the absence of K1. Photocleavage
assay results published in the same work were interpreted
to imply the binding of only 2 drug mol TMPyP4/mol
quadruplex, both binding to end-cap regions. It is our belief
that the intercalated TMPyP4 molecules would have had a
smaller light absorption cross section than drug molecules in
the end-capped positions. This is consistent with the
hypochromicity observed in this study for the addition of
TMPyP4 at mole ratios .2. In effect, photocleavage would
occur predominantly near the end-capped TMPyP4 mole-
cules and not near those that were intercalated. Haq et al., on
the other hand, in other quadruplexmodel systems, stated that
the quadruplex would be saturated with only 2 mol TMPyP4/
mol oligonucleotide, both occupying intercalation cavities in
the quadruplex structure comprised of four stacked G-tetrads
(39). Our data indicate that overlapping end-capping and in-
tercalation interactions are present in the binding of TMPyP4
to the 27-mer quadruplex DNA construct.
All of our experimental data are consistent with a model
for the binding of TMPyP4 to the 27-mer quadruplex that
features 1), the presence of four TMPyP4 binding sites in
the quadruplex; 2), the existence of two binding modes, one
in which the favorable free energy change is partly due to a
favorable entropy change and a second in which the favorable
free energy change is opposed by an unfavorable entropy
contribution; and 3), binding modes that each consist of two
thermodynamically equivalent ligand-binding sites.
We conclude with a statement that this system is
extremely complex. The c-MYC 27-mer sequence is theo-
retically capable of forming multiple folded quadruplex
structures with both chain (parallel and antiparallel) and loop
(1:6:1, 1:2:1, . . .) isomers. In the work presented here, we
report average thermodynamic parameters for binding of up
to 4 mol TMPyP4 to an unknown mixture of quadruplex
species. We have discussed that there are at least two con-
formers present with differing thermal stability, and that
the lower-melting conformer(s) appears to have the higher
afﬁnity for TMPyP4. We have also gone out on a limb and
suggested that our data are consistent with the native c-MYC
sequence existing as a mixture of 1:6:1 and 1:2:1 intramo-
lecular propeller-type parallel-stranded quadruplex struc-
tures, with TMPyP4 being preferentially bound to the 1:6:1
loop isomer.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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